α‐Catulin downregulates E‐cadherin and promotes melanoma progression and invasion

Metastasis is associated with poor prognosis for melanoma responsible for about 90% of skin cancer‐related mortality. To metastasize, melanoma cells must escape keratinocyte control, invade across the basement membrane and survive in the dermis by resisting apoptosis before they can intravasate into the circulation. α‐Catulin (CTNNAL1) is a cytoplasmic molecule that integrates the crosstalk between nuclear factor‐kappa B and Rho signaling pathways, binds to β‐catenin and increases the level of both α‐catenin and β‐catenin and therefore has potential effects on inflammation, apoptosis and cytoskeletal reorganization. Here, we show that α‐catulin is highly expressed in melanoma cells. Expression of α‐catulin promoted melanoma progression and occurred concomitantly with the downregulation of E‐cadherin and the upregulation of expression of mesenchymal genes such as N‐cadherin, Snail/Slug and the matrix metalloproteinases 2 and 9. Knockdown of α‐catulin promoted adhesion to and inhibited migration away from keratinocytes in an E‐cadherin‐dependent manner and decreased the transmigration through a keratinocyte monolayer, as well as in Transwell assays using collagens, laminin and fibronectin coating. Moreover, knockdown promoted homotypic spheroid formation and concomitantly increased E‐cadherin expression along with downregulation of transcription factors implicated in its repression (Snail/Slug, Twist and ZEB). Consistent with the molecular changes, α‐catulin provoked invasion of melanoma cells in a three‐dimensional culture assay by the upregulation of matrix metalloproteinases 2 and 9 and the activation of ROCK/Rho. As such, α‐catulin may represent a key driver of the metastatic process, implicating potential for therapeutic interference.

[1]  L. Cornelius,et al.  The role of chemokines in melanoma tumor growth and metastasis. , 2002, The Journal of investigative dermatology.

[2]  D. Elder,et al.  E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. , 2000, The American journal of pathology.

[3]  A. Bosserhoff,et al.  Loss of E-cadherin Expression in Melanoma Cells Involves Up-regulation of the Transcriptional Repressor Snail* , 2001, The Journal of Biological Chemistry.

[4]  S. Hirohashi,et al.  E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. , 1994, Journal of cell science.

[5]  M. G. Cook Diagnosis of thin melanoma. , 1997, Journal of clinical pathology.

[6]  H. Beug,et al.  Molecular requirements for epithelial-mesenchymal transition during tumor progression. , 2005, Current opinion in cell biology.

[7]  C. Bucana,et al.  Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis , 2001, Oncogene.

[8]  C. Berking,et al.  Function and regulation of melanoma–stromal fibroblast interactions: when seeds meet soil , 2003, Oncogene.

[9]  David Polsky,et al.  Focus on melanoma. , 2002, Cancer cell.

[10]  S. Dedhar,et al.  Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells , 2004, Oncogene.

[11]  J. Thiery Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[12]  M. Herlyn,et al.  Normal human melanocyte homeostasis as a paradigm for understanding melanoma. , 2005, The journal of investigative dermatology. Symposium proceedings.

[13]  A. Bosserhoff,et al.  Loss of E-cadherin leads to upregulation of NFκB activity in malignant melanoma , 2004, Oncogene.

[14]  G. Berx,et al.  The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program. , 2005, Cancer research.

[15]  R C Bates,et al.  Spheroids and cell survival. , 2000, Critical reviews in oncology/hematology.

[16]  J. Thiery [Epithelial-mesenchymal transitions in cancer onset and progression]. , 2009, Bulletin de l'Academie nationale de medecine.

[17]  V. Sondak,et al.  Early stage (I, II, III) melanoma , 2001, Current treatment options in oncology.

[18]  W. Birchmeier,et al.  The E-cadherin promoter: functional analysis of a G.C-rich region and an epithelial cell-specific palindromic regulatory element. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Richmond,et al.  Role of nuclear factor-κ B in melanoma , 2005, Cancer and Metastasis Reviews.

[20]  W. Gerald,et al.  Identifying site-specific metastasis genes and functions. , 2005, Cold Spring Harbor symposia on quantitative biology.

[21]  S. Amatschek,et al.  CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells , 2010, British Journal of Cancer.

[22]  D. Toksoz,et al.  Distinct Activities of the α-Catenin Family, α-Catulin and α-Catenin, on β-Catenin-Mediated Signaling , 2004, Molecular and Cellular Biology.

[23]  M. Levine,et al.  dorsal-twist interactions establish snail expression in the presumptive mesoderm of the Drosophila embryo. , 1992, Genes & development.

[24]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[25]  M. Herlyn,et al.  Shifts in cadherin profiles between human normal melanocytes and melanomas. , 1996, The journal of investigative dermatology. Symposium proceedings.

[26]  T. Hong,et al.  α-Catulin knockdown induces senescence in cancer cells , 2011, Oncogene.

[27]  M. Idoate,et al.  Expression and serum levels of MMP‐2 and MMP‐9 during human melanoma progression , 2005, Clinical and experimental dermatology.

[28]  A. Halpern,et al.  Model predicting survival in stage I melanoma based on tumor progression. , 1989, Journal of the National Cancer Institute.

[29]  A. Nagafuchi Molecular architecture of adherens junctions. , 2001, Current opinion in cell biology.

[30]  D. Ruiter,et al.  Matrix metalloproteinases in human melanoma. , 2000, The Journal of investigative dermatology.

[31]  H. Pehamberger,et al.  Identification of genetic disparity between primary and metastatic melanoma in human patients , 2011, Genes, chromosomes & cancer.

[32]  W. Clark Human cutaneous malignant melanoma as a model for cancer , 1991, Cancer and Metastasis Reviews.

[33]  J C Briggs,et al.  Cutaneous melanoma. , 1993, Journal of the American Academy of Dermatology.

[34]  J. Testa,et al.  Association of Lbc Rho Guanine Nucleotide Exchange Factor with α-Catenin-related Protein, α-Catulin/CTNNAL1, Supports Serum Response Factor Activation* , 2002, The Journal of Biological Chemistry.

[35]  F. Roy,et al.  α-Catulin, a Rho signalling component, can regulate NF-κB through binding to IKK-β, and confers resistance to apoptosis , 2008, Oncogene.

[36]  P. Guilford E-cadherin downregulation in cancer: fuel on the fire? , 1999, Molecular medicine today.

[37]  Tony Hunter,et al.  Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. , 2003, Cancer cell.

[38]  J. Becker,et al.  Coexpression of Integrin αvβ3 and Matrix Metalloproteinase-2 (MMP-2) Coincides with MMP-2 Activation: Correlation with Melanoma Progression , 2000 .

[39]  Jae Kwon Lee,et al.  Activation of professional antigen presenting cells by acharan sulfate isolated from giant african snail, achatina fulica , 2007, Archives of pharmacal research.